Kaixin Jieyu Pills Up-Regulated PPARα/FGF21/FGFR1 Pathway to Improve Depression-Like Behavior in Chronic Unpredictable Mild Stress Model Rats
- VernacularTitle:开心解郁丸上调PPARα/FGF21/FGFR1通路改善慢性不可预知温和应激模型大鼠的抑郁样行为
- Author:
Wujianwen ZHAI
1
;
Fengmei YANG
;
Yujing JIN
;
Rui YANG
;
Shijing HUANG
;
Juhua PAN
;
Yuxia CHEN
Author Information
- Keywords: Kaixin Jieyu Pill; Depression; Peroxisome proliferator activated receptorα; Fibroblast growth factor 21; Fibroblast growth factor receptor; Liver governing free flow of qi
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2023;25(12):3829-3836
- CountryChina
- Language:Chinese
- Abstract: Objective To explore the effects of Kaixin Jieyu Pill(KJP)on peroxisome proliferator-activated receptor alpha(PPARα),serum and hippocampal tissue fibroblast growth factor 21(FGF21)and hippocampal tissue fibroblast growth factor receptor 1(FGFR1)in rats with depression model.Methods A rat chronic stress model was prepared using the chronic unpredictable mild stimulus method(CUMS)to observe behavioral changes in depression.Hippocampal FGF21,FGFR1 and liver PPARα protein and mRNA expression levels were measured in hippocampal tissues by western blot and real-time fluorescence quantification(RT-qPCT).Results The expression levels of PPARα,FGF21 and FGFR1's protein and their mRNA were dramatically decreased in the CUMS model rats compared with the normal group(P<0.001).KJP could modify the depressive-like behaviors of rats(P<0.001),upregulate the protein expression level of PPARα,FGF21,and FGFR1(P<0.05,P<0.01,P<0.01);markedly modify the mRNA expression levels of PPARα,FGF21,and FGFR1(P<0.001,P<0.01,P<0.01).Conclusion PPARα/FGF21/FGFR1 pathway may participate in the pathogenesis of depression;upregulation of PPARα/FGF21/FGFR1 pathway may be related to the antidepressant mechanism of KJP.
